Lam Research Corporation $LRCX is Talos Eurisko Asset Management LP’s 7th Largest Position

Talos Eurisko Asset Management LP boosted its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 32.6% during the 2nd quarter, Holdings Channel reports. The firm owned 279,834 shares of the semiconductor company’s stock after buying an additional 68,834 shares during the period. Lam Research comprises about 6.5% of Talos Eurisko Asset Management LP’s portfolio, making the stock its 7th biggest holding. Talos Eurisko Asset Management LP’s holdings in Lam Research were worth $27,239,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BankPlus Wealth Management LLC raised its position in shares of Lam Research by 2.0% during the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after buying an additional 105 shares during the last quarter. ORG Partners LLC boosted its position in shares of Lam Research by 7.3% during the second quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock worth $162,000 after acquiring an additional 114 shares during the last quarter. Quotient Wealth Partners LLC grew its stake in Lam Research by 2.1% during the second quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock valued at $529,000 after acquiring an additional 114 shares in the last quarter. Fairvoy Private Wealth LLC grew its stake in Lam Research by 3.0% during the second quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after acquiring an additional 120 shares in the last quarter. Finally, Rosenberg Matthew Hamilton increased its holdings in Lam Research by 16.0% in the 2nd quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company’s stock valued at $85,000 after acquiring an additional 120 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the sale, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by company insiders.

Lam Research Stock Down 2.9%

Shares of LRCX opened at $143.24 on Wednesday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The business has a fifty day moving average of $142.35 and a 200 day moving average of $110.96. The company has a market cap of $179.91 billion, a PE ratio of 31.55, a P/E/G ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the firm posted $0.86 earnings per share. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a report on Monday. Barclays set a $142.00 target price on Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. UBS Group set a $165.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, October 23rd. Stifel Nicolaus set a $160.00 target price on shares of Lam Research and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Hsbc Global Res raised shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $149.04.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.